Jay Rughani is a partner on the Bio investing team, where he focuses on companies that use software and data to accelerate medical research, streamline healthcare operations, and enable people to live healthier and happier lives.
Prior to a16z, Jay was part of the team at Flatiron Health (acquired by Roche). There, he helped to build some of the company’s first data & analytics software products used by biopharmaceutical companies to study real-world cancer care. He went on to develop numerous commercial partnerships with large biopharma companies, smaller biotechs, and other research organizations.
Previously, Jay advised large healthcare and technology organizations on corporate growth initiatives at Deloitte and supported various go-to-market, product, and capital raising initiatives at DealerMatch (acquired by Cox Enterprises).
Jay received a B.A. in Mathematics & Economics at Emory University and grew up in Clearwater, FL and London, UK.